Answer
Apr 30, 2025 - 09:21 AM
Janumet, a combination of metformin and sitagliptin, is used to manage type 2 diabetes. While it is generally considered safe when prescribed by a healthcare provider, it carries some risks, such as lactic acidosis from metformin and potential pancreatitis from sitagliptin. Patients should discuss their individual risk factors with their healthcare provider to determine if Janumet is appropriate for them.
